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Sentinel node mapping is becoming a routine procedure for staging of various malignancies, because it can determine lymph
node status more precisely. Due to anatomical problems, localizing sentinel nodes in the head and neck region on the basis of
conventional images can be diﬃcult. New diagnostic tools can provide better visualization of sentinel nodes. In an attempt to keep
up with possible scientiﬁc progress, this article reviews new and innovative tools for sentinel node localization in this speciﬁc area.
The overview comprises a short introduction of the sentinel node procedure as well as indications in the head and neck region.
ThentheresultsofSPECT/CTforsentinelnodedetectionaredescribed.Finally,aportablegammacameratoenableintraoperative
real-time imaging with improved sentinel node detection is described.
Copyright © 2009 L. Vermeeren et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Sentinel lymph node biopsy is increasingly being used as
a staging procedure for various malignancies. The sentinel
node can be deﬁned as the lymph node on the direct
drainage pathway from the primary tumor [1]. Therefore,
this particular node is likely to be the ﬁrst node to harbor
metastasis and can be used to provide information about the
rest of the nodal basin. Based on the hypothesis of sequential
tumor spread, sentinel node mapping can be used for nodal
staging, being more precise than imaging procedures and
less invasive than regional prophylactic nodal dissection. In
melanoma, the sentinel node status has proven to provide
relevant prognostic information and is widely performed
to accurately stage melanoma patients [2]. The procedure
has evolved to a routine staging method for patients with
clinically localized breast cancer and is nowadays used to
stage patients with other solid tumors as well. The role of
sentinel node biopsy has not been clearly deﬁned for head
and neck squamous cell carcinoma. Positive sentinel nodes
have shown to be a negative prognostic factor in oral cancer
[3]andseveralauthorshavepublishedgoodresultsregarding
staging accuracy of the sentinel node biopsy in oral cancer
patients[4–6].Itcanbeusedtoselectpatientsforsubsequent
neck dissection and can reduce morbidity in many sentinel
node negative patients who can be spared this operation.
Conventional planar lymphoscintigraphy is routinely
used for preoperative sentinel node detection and localiza-
tion. Dynamic planar images can show the draining lymph
vessels directly after injection, while sequential static planar
images show an overview of the number and localization of
the sentinel nodes. Sentinel nodes are often clearly visualized
with planar images and the levels of these nodes can be
localizedusingexternalradioactivemarkers,suchasacobalt-
57-source pen. Interpretation of planar images can be diﬃ-
cult because the anatomy information is limited to outlining2 Journal of Oncology
the body contour. Especially sentinel nodes in the head and
neck region can be diﬃcult to localize, as a result of complex
anatomy, interlacing lymphatic vessels, unexpected drainage
patterns and because the three-dimensional surface of the
structures of the head is not visualized on planar images.
Furthermore, sentinel nodes in proximity to the injection
area, for example, in the preauricular or submandibular
region, can easily be missed on planar images.
Intraoperative sentinel node detection with the gamma
ray detection probe can be challenging as well. More than
95% of the administered radioactivity stays behind at the
injection site and may cause nearby located sentinel nodes
to be missed. Distinguishing sentinel nodes from second-
echelon nodes with the probe is not possible and, as no
overview can be provided, certainty about removal of all
radioactive sentinel nodes is not provided by the gamma
probe.
The complexity of the anatomy in the head and neck
region requires optimization of sentinel node detection and
localization in this area. First, we will report on the clinical
indication for sentinel node mapping in head and neck
malignancies. Then we will outline recent innovations to
improve radioguided lymph node surgery in the head and
neck area and we will report on our own preliminary results
with those innovative imaging techniques.
2. Indication for Sentinel Node Mapping in the
Head andNeck Region
As sentinel node mapping in the head and neck region is
usedforlymphnodestaging,onlypatientswithclinicallyand
radiologically negative lymph node assessment (stage N0)
are considered for this procedure. If enlarged lymph nodes
are found by physical examination or ultrasound aspiration
cytology, the presence of nodal metastases can be conﬁrmed
and patients can proceed to selective or (modiﬁed) radical
neck dissection.
Controversy exists regarding the appropriate indication
for sentinel node biopsy in melanoma and squamous cell
carcinoma. The indication for sentinel node mapping in
melanoma generally depends on the Breslow thickness of
the tumor, although ulceration and other prognostic factors
might also be taken into account [7]. In thin lesions, the
low risk of ﬁnding nodal metastases can be a reason to
omit sentinel node staging and many authors do not use
sentinel node biopsy in such lesions (e.g., less than 0.75mm
or less than 1.0mm) [8]. In thick lesions, the high risk of
synchronous distant metastases may outweigh the possible
therapeutic and prognostic beneﬁts of lymphadenectomy or
sentinel node mapping [9, 10].
The exact role of lymph node staging with sentinel
node biopsy in oral cancer has not been clearly deﬁned
yet, though several authors use the procedure to stage T1
or T1 and T2 lesions [4–6]. A diagnostic meta-analysis
by Paleri et al. showed a good sensitivity (92.6%) of the
sentinel node procedure in squamous cell cancer of the oral
cavity an oral pharynx [5], while Civantos Jr. et al. found a
negative predictive value of 96% for this procedure [4]. The
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Figure1:SPECT/CTtoruleoutapresumedsentinelnode.Anterior
(a) and oblique (b) planar static images after 2 hours show drainage
totherightneckonthebasisofwhich3sentinelnodesweremarked.
SPECT/CT (c) demonstrates the cranial hotspot located at the base
ofthetongueintheoropharynx(arrow),duetoleakageofthetracer
from the injection area. The sentinel nodes are clearly visualized
with SPECT/CT (d), while three-dimensional reconstruction (e)
shows an anatomic overview of all hotspots.
lesser morbidity of sentinel node biopsy is often used as an
argument against elective neck procedures; however some
authors ﬁnd selective neck dissection more appropriate inJournal of Oncology 3
(a) (b)
(c) (d)
(e)
Figure 2: SPECT/CT localizing sentinel nodes and providing
anatomic overview. Anterior (a) and oblique (b) planar static
images after 2 hours show several hotspots. Two-dimensional
SPECT/CT reconstruction exactly localizes each node, for example,
localizing 2 sentinel nodes in the submandibular region (c).
Three-dimensional SPECT/CT reconstruction shows an anatomic
overview of all sentinel nodes (d) and (e).
view of the high risk of nodal metastasis [11]. This especially
is true in patients with more advanced lesions.
3.SPECT/CTfor PreoperativeSentinel
Node Detection
Hybrid single-photon emission computed tomography with
integrated computed tomography (SPECT/CT) is a mul-
timodal imaging device and can be used to visualize and
localize sentinel nodes [12–20]. SPECT/CT can optimize
(a) (b)
(c)
Figure 3: Development of portable gamma cameras. (a) First
generation portable gamma camera with a weight of approximately
2kg. (b) Portable gamma camera with a weight < 1kgbutwithout
support system. (c) Last generation portable gamma camera with
improved ergometrical details and adequate support system for
intraoperative use.
sentinel node visualization which may lead to improved
intraoperative detection [21]. A SPECT/CT system gener-
ally consists of a dual-head variable-angle gamma camera
equipped with low-energy high-resolution collimators and a
multislice spiral CT optimized for rapid rotation. A matrix
128 × 128 is used for SPECT acquisition and 25 seconds per
view using 4–6-degree-angle steps enable adequate images.
The CT settings are aimed at obtaining a low-dose CT
(e.g., 130KV, 40mAs, B30s kernel), which is appropriate for
attenuation correction and mapping. A major advantage of
the hybrid SPECT/CT system is that the patient need not
be moved between the SPECT and the CT data acquisition.
After reconstruction, the SPECT images are corrected for
attenuation and scatter. Axial 5mm SPECT and CT slices
are usually generated. Subsequently, the SPECT and CT
images are fused and can be displayed using multiplanar
reconstruction projection with two-dimensional orthogonal
reslicing in axial, sagittal, and coronal orientation and
maximum intensity projection. A three-dimensional image4 Journal of Oncology
Table 1: Technical details of SPECT/CT in head and neck malignancies in various studies.
Study N∗ Malignancy Dose Injection Planar Imaging Timing
SPECT/CT SPECT Surgery Details
Even-
Sapir et
al. [12]
9 3H N M
6O C C 74MBq
Intradermal or
submucosal
injection 4
peritumoral
deposits of
0.4mL each
Sequential
images within
minutes after
injection until
visualization
(up to 24 hours)
Not
speciﬁed
3◦
angle/20s to
25s steps
Matrix:
128 ×128
Next day
Total number
of patients:
34 (9 head
and neck
malignancy)
Wagner
et al. [13] 30 OCC 20MBq
Intra-
mucodermal
injection 2
peritumoral
deposits of
0.05mL each
Static image 60
minutes after
injection
60 minutes
after
injection
6◦
angle/30s
steps
Matrix:
128 ×128
Same day
Sentinel node
biopsy
performed in
13/30
Lopez et
al. [14] 10 OCC 22.2MBq
4 peritumoral
deposits Total
volume
<0.5mL
Sequential
images 4 to 24
hours after
injection
Not
speciﬁed
6◦
angle/10s
steps
Matrix:
128 ×128
Same day
Image
registration
performed
manually by
reprojection
Thomsen
et al. [15] 37 OCC 20MBq
4–6
peritumoral
submucosal
deposits Total
volume 0.2mL
Static images
30–60 minutes
after injection
Not
speciﬁed
6◦ angle/8s
steps
Matrix:
128 ×128
Same day
SPECT/CT in
3 7o u to f4 0
patients
Terada et
al. [16] 12 OCC 18.5MBq
4 peritumoral
submucosal
deposits,
volume
unclear
As t a t i cl y m -
phoscintigram
(anterior and
bilateral
oblique) was
performed
After
planar
images
Not
speciﬁed Same day
Results of
SPECT/CT
are not
compared to
results of
planar
imaging
Bilde et
al. [17] 34 OCC
120MBq
or
60MBq§
4 peritumoral
submucosal
deposits Total
volume 0.2mL
Dynamic
imaging (lateral
and anterior)
during 20
minutes Static
images after 30
and 90 minutes
After
planar
images
3◦
angle/30s
steps
Matrix:
128 ×128
Some the
next day,
some the
same day
Khaﬁf et
al. [18] 20 OCC 74MBq
Injection at the
border of the
primary tumor
4 deposits of
0.4mL each
Sequential
images within
minutes until
visualization
(up to 24 hours)
Not
speciﬁed
3◦ angle /
20s–25s
steps
Matrix:
128 ×128
Next day
Keski-
S¨ antti et
al. [19]
15 OCC 74MBq
Peritumoral
injection in 1
or 2 deposits
Total volume
0.2mL
Planar lym-
phoscintigraphy
with anterior
and lateral
projections
Not
speciﬁed
Not
speciﬁed Next dayJournal of Oncology 5
Table 1: Continued.
Study N∗ Malignancy Dose Injection Planar Imaging Timing
SPECT/CT SPECT Surgery Details
Covarelli
et al. [20]
12
ver-
sus
11±
HNM 50MBq or
10 MBq§
Peritumoral
intradermal
injection in 4
deposits In
case of
excision: 2
deposits
around
surgical scar
Total volume
0.1mL
Dynamic planar
imaging for 20
minutes
Sequential static
images up to
until 3 hours
45 minutes
after
injection
4◦ angle /
30s steps
Matrix:
256 ×256
Some the
next day,
some the
same day
Patients
received
either planar
imaging or
SPECT/CT
∗number of patients with a head and neck malignancy that received SPECT/CT.
HNM: head and neck melanoma.
OCC: oral cavity carcinoma.
§ the ﬁrst dose was injected if patients were operated the next day; the last dose was injected if patients were operated the same day.
± 12 patients received SPECT/CT only; 11 patients received planar imaging only.
display can also be constructed, based on volume rendering
of fused SPECT/CT images with a 16-bit color look-up table
with deﬁned opacity for soft tissue, bone, and skin. Based
on this three-dimensional view, the opacity can be manually
adjusted to visualize these structures with diﬀerent colors:
redformuscle,ochreforbone,andblueforskin.Thesentinel
node is displayed in yellow (Figures 1 and 2)i nb o t ht w o -
dimensional and three-dimensional display. Sentinel lymph
nodescanbeidentiﬁedandlocalizedonthetwo-dimensional
images, while three-dimensional reconstruction gives an
anatomic overview of all lymph nodes in relation to the
injection area.
Several authors have reported on the use of SPECT/CT
in head and neck malignancies; previous study details are
s u m m a r i z e di nT a b l e1. The injected dose varies among
the diﬀerent studies as well as planar imaging protocols
and timing of SPECT/CT and sentinel node excision. The
injected dose depends on the time to operation. A larger
dose of radioactivity is needed with a longer interval because
of the physical half-life of the radionuclide. A dosage of
10MBq–60MBq radioactive colloid is used when patients
areoperatedonthesameday,while50MBq–120MBqisused
when operation takes place the next day. If low dosages are
used, lymphatic vessels may not be visualized, which leads to
diﬃculty in identifying sentinel nodes.
The results of additional imaging with SPECT/CT are
s u m m a r i z e di nT a b l e2. Numbers of patients studied are
rather small in all studies and exact drainage visualization
numbers are not mentioned in every study. Recorded
visualization of lymphatic drainage on planar images ranges
from 83% to 100%. SPECT/CT has proven to visualize
additionalsentinelnodesinmorethanhalfofthestudies[12,
13, 15, 17–19], although the authors of one study conclude
that SPECT/CT rarely reveals sentinel nodes that are not
detected on planar images [19]. Especially nodes adjacent to
the injection area appear to be detected by SPECT/CT, while
these are easily missed on planar images [13, 15]. In 3 out
of 9 studies, presumed sentinel nodes could be interpreted as
nonnodaltraceruptake(tracerleakageorcontamination)on
the basis of SPECT/CT images [12, 18, 19]. All authors agree
that SPECT/CT provides useful localization information
[12–20]. Covarelli et al. have proven the clinical relevance of
this localization information, since the operation time was
signiﬁcantly less when sentinel node surgery was performed
onthebasisofSPECT/CTimagescomparedtoplanarimages
[20].
OurownpreliminaryresultswithSPECT/CTinheadand
neck malignancies are in line with the literature ﬁndings.
The visualization rate was 100% for planar imaging as
well as SPECT/CT in the ﬁrst 33 patients, but SPECT/CT
visualized additional sentinel nodes in 18% of the patients
and excluded hotspots as being sentinel nodes in 9% of
all patients. Figure 1 shows an example of a hotspot that
was assumed to be a sentinel node but which SPECT/CT
showed to be caused by tracer leakage in the oral cavity
on SPECT/CT. The exact anatomic localization could be
realized with SPECT/CT in all patients. An example of
anatomic localization with SPECT/CT is given in Figure 2.
In our hospital, surgical incisions are based on SPECT/CT
images, because of the anatomic localization and overview
SPECT/CT images provide.
Combining our results with literature ﬁndings,
SPECT/CT appears to be very useful for exact anatomic
localization of the sentinel nodes. In the head and neck
area it is of considerable importance to identify the relation
of sentinel nodes to several vital vascular and neural
structures in order to be able to safely remove these nodes.
SPECT/CT also detects sentinel nodes that are missed on
planar lymphoscintigraphy in a substantial number of
patients. In head and neck cancer, many sentinel nodes
are located in close proximity to the injection area and
are easily overlooked on planar images. Cases of nonnodal
tracer uptake (e.g., tracer leakage in the oral cavity after
injection or contamination on the skin) can be identiﬁed
with SPECT/CT, while distinguishing between leakage and a
sentinel node on planar images is often impossible.
After tracer administration (intradermally in melanoma,
submucosally in oral cavity carcinoma), sequential planar6 Journal of Oncology
Table 2: SPECT/CT results in various studies.
Study
Visualization
with planar
imaging
Visualization
with SPECT/CT
Additional sentinel
nodes visualized
with SPECT/CT
Main conclusions with regards
to imaging
Even-Sapir et
al. [12]
Multiple
drainage
basins: 11%
Multiple drainage
basins: 33%
Additional
clinical relevant
information with
SPECT/CT: 44%
In 3 out of 9
patients 1 false
positive node
excluded
SPECT/CT provides
additional data of clinical
relevance in patients with
trunk or head and neck
melanoma and patients with
mucosal head and neck tumor.
Wagner et al.
[13]
38 sentinel
nodes
Sentinel node
visualization with
planar imaging
and SPECT/CT:
90% 49 sentinel
nodes
11 sentinel nodes
SPECT/CT is feasible for
sentinel node detection.
SPECT/CT enhances
topographic orientation and
diagnostic sensitivity.
SPECT/CT is necessary to
identify nodes adjacent to the
primary lesion.
Lopez et al.
[14]
Sentinel node
visualization:
100%
Localization of
the sentinel nodes
in 9/10 patients
Multimodal registration is an
eﬀective method for anatomic
localization of the sentinel
nodes in N0 oral squamous
cell carcinoma.
Thomsen et al.
[15]
99 sentinel
nodes
SPECT/CT and
added oblique
planar images:
123 sentinel
nodes
24 extra sentinel
nodes found with
SPECT/CT in
combination with
added oblique
planar images
Added oblique planar images
and/or SPECT/CT detect extra
clinical relevant hotspots in
38% of the patients. Sentinel
lymph nodes close to injection
area are diﬃcult to ﬁnd.
Terada et al.
[16]
Sentinel node
visualization with
planar imaging
and SPECT/CT:
100%
Intraoperative sentinel node
biopsy based on SPECT/CT
images is an easy, accurate,
and reliable method.
Analysing the three hottest
sentinel nodes reliably
predicts a patients neck status.
Bilde et al. [17] 88 sentinel
nodes
Sentinel node
visualization:
94% 107 sentinel
nodes
19 sentinel nodes
I n1 5o u to f3 2
patients (47%)
Correction of anatomic level
with SPECT/CT in 22%.
Reclassiﬁcation of anatomic
level during surgery in 22%.
SPECT/CT detects more
sentinel nodes and provides
additional anatomical and
spatial information.
K h a ﬁ fe ta l .
[18]
Sentinel node
visualization with
planar imaging
and SPECT/CT:
95% SPECT/CT
added signiﬁcant
anatomical
preoperative
information in 6
out of 20 patients
(30%)
Additional sentinel
n o d e ss e e ni n2
patients
(metastatic
sentinel node in 1)
Exclusion of
sentinel nodes in 4
patients (all
activity at injection
site)
SPECT/CT sentinel node
mapping provides additional
preoperative data of clinical
relevance.Journal of Oncology 7
Table 2: Continued.
Study
Visualization
with planar
imaging
Visualization
with SPECT/CT
Additional sentinel
nodes visualized
with SPECT/CT
Main conclusions with regards
to imaging
Keski-S¨ antti et
al. [19]
Sentinel node
visualization:
100%
Sentinel node
visualization:
100% Additional
data provided by
SPECT/CT was
considered
clinical relevant
in 6 out of 15
patients (40%)
1 additional
sentinel node
visualized 2 false
positive nodes
excluded
SPECT/CT enables more
accurate localization of
sentinel nodes. SPECT/CT
rarely reveals sentinel nodes
that are not detected on
planar images.
Covarelli et al.
[20]
Sentinel node
visualization:
83% 12
sentinel nodes
in 12 patients
Sentinel node
visualization:
100% 13 sentinel
nodes in 12
patients
SPECT/CT is more eﬀective
and reliable than planar
lymphoscintigraphy. Sentinel
node biopsy takes signiﬁcantly
less time in the SPECT/CT
group.
Table 3: Requirements for intra-operative imaging.
Portable gamma camera
(1) Manageable design (portable and stable)
(2) Suﬃcient resolution and detection sensitivity
(3) No delay between image acquisition and display (real-time imaging)
(4) Adequate ﬁeld of view
Intra-operative situation
(5) No interference with ﬁeld of operation
(6) Possibility for continuous monitoring
(7) Spatial orientation on screen
(8) Possibility to use pointers for position and localization
(9) Real-time quantiﬁcation of the number of counts per second
Sentinel node (10) Suﬃcient uptake of the radiotracer by the sentinel node
images can identify nodes that are on a direct drainage
pathway from the primary tumor (sentinel nodes). Subse-
quently, SPECT/CT can localize these sentinel nodes, giving
anatomical reference points for the planning of the surgical
approach.
4. Portable Gamma Cameras for
IntraoperativeImaging
Sentinelnodesurgeryisbasedonthecombinationofgamma
probe detection and blue dye mapping. Surgeons localize
sentinel nodes combining the auditive signal (probe) to the
visual one (blue dye). In head and neck patients, the use
of blue dye can be problematic. The injection of blue dye
in the mouth can lead to obscured tumor edges and thus
interfere with resection [18]. Furthermore, blue dye shifts
very fast. For these reasons the application of blue dye in
head and neck patients, with a high density of lymph nodes
and short distances between injection site and sentinel node,
is limited. The incorporation of another visual element in
sentinel node surgery of the head and neck can facilitate
the procedure. Against this background, portable gamma
camerashavebeendesignedtofacilitateradioguidedsurgery.
The development of such cameras is illustrated in Figure 3.
While the ﬁrst prototypes were heavy hand-held devices, the
new generation of portable gamma cameras is equipped with
a stable support system.
The use of portable gamma cameras has been described
in parathyroidectomy [22, 23]. The parathyroid adenomas
can be located intraoperatively by means of sestamibi
imaging using a portable gamma camera [22, 23]. Another
possible application of the portable gamma camera can
be localizing lymph nodes [24–26]. Exact localization of
sentinel nodes by the portable gamma camera was shown
in an animal model [27], and recently the synchronous use
of a portable gamma camera and gamma probe showed
exact localization of sentinel nodes in 11 breast cancer
patients [28]. Furthermore, the depth of the sentinel nodes
was successfully estimated preoperatively using the portable
gamma camera [28]. Several conditions are required to
optimize intraoperative imaging with the portable gamma
camera.AsummaryoftheserequirementsisgiveninTable3.8 Journal of Oncology
(a) (b)
(c) (d)
Figure 4: Localization and postexcision monitoring. Continuous monitoring (a) provides the possibility to record the whole procedure.
With stepwise monitoring (b), the sentinel nodes are localized ﬁrst, then excision takes place, and afterwards the portable gamma camera is
used to screen for remaining activity. The laser pointer is positioned above the previous marked sentinel node level and the camera displays
the technetium-signal (c), indicating that the node is located just right from the laser pointer. The portable gamma camera can also give an
overview of the surgical ﬁeld (d). It shows the injection area with a sentinel node located more caudally. After excision, the camera clearly
shows no remaining radioactivity (d).
In our centre, the use of a portable gamma camera
was introduced for laparoscopic lymph node localization
in urological malignancies [29] and has recently been
commenced to aid lymph node localization in oral cavity
carcinoma as well. The portable gamma camera (Sentinella,
S102, GEM imaging, Valencia, Spain) is equipped with
a 4mm pinhole collimator and uses a CsI(Na) contin-
uous scintillating crystal. The pinhole collimator enables
visualization of the whole surgical ﬁeld and the ﬁeld of
view depends on the distance between the camera and
the imaging plane. The ﬁeld of view is 4 × 4cm when
placed at 3cm from the imaging plane and increases to
20 × 20cm when placed at a distance of 15cm. The
intrinsic spatial resolution is 1.8mm. The extrinsic spatial
resolution values are 7mm and 21mm for a distance of
3cm and 15cm, respectively. The detection sensitivity for
this collimator depends on the distance to the imaging
plane, being 708 and 41cpm/uCi for distances of 3cm and
15cm respectively. These and other technical details of this
portable gamma camera are described by S´ anchez et al.
[24].
Intraoperative real-time imaging with the portable
gamma camera provides an overview of all radioactive
hotspots in the whole surgical ﬁeld. Its position can be
adjusted to also show sentinel nodes near to the injection
area, which are easily overlooked using the probe. The
diﬀerentiation between sentinel nodes and secondary tier is
facilitated, because the amount of radioactivity within each
node can be quantiﬁed with the portable gamma camera and
the intraoperative images can be related to the preoperative
scintigraphic images. Furtheremore, sentinel nodes can be
exactly localized by on screen visualization, besides the
audiological localization by the laparoscopic gamma probe.
Figure 4 shows 2 possibilities for intra-operative use of the
portable gamma camera. Continuous monitoring can be
used to record the whole procedure and stepwise monitoring
enables localization of sentinel nodes and detects remaining
activity afterwards. If the laser pointer signal matches the
technetium signal on screen, this indicates that the sentinel
node has been exactly localized. Another clear advantage of
the portable gamma camera is the certainty it can provide
about the completeness and accuracy of the sentinel node
excision, since it shows remaining radioactivity. Figure 4
also shows the comparison of the situation before and after
excision.
As experience with radioguided surgery is gained, the
need for advanced imaging modalities will increase. The
portable gamma camera is an innovative tool that can
improve nodal excision in areas with complex anatomy.
Further research in our institute is underway to deﬁne the
exact value and indication of the intraoperative use of a
portable gamma camera.Journal of Oncology 9
5. FutureDirections
Over the next years, the use of SPECT/CT might become
routine procedure for patients with diﬃcult to interpret pla-
nar images. The major challenge remains to optimize intra-
operative visualization of sentinel nodes. The development
of a gamma camera with a multiplanar detection system
(e.g., two heads) might enable real-time three-dimensional
visualization. Furthermore, the development of new tracers
may improve intraoperative visualization as well. A slower
migrating alternative to patent bluemight improve thedirect
intraoperative localization of sentinel nodes in the neck.
Another option may be the development of a dual-tracer,
which contains radioactivity as well as color and can be
used for lymphoscintigraphy and intraoperative visual and
auditive (gamma probe) at the same time.
6. Conclusion
Sentinel node biopsy is increasingly being used to provide
accurate staging in early stage head and neck malignancies,
such as melanoma and oral squamous cell carcinoma.
Lymphatic mapping in the head and neck area can be
complicated because of the complex anatomy and variable
drainagepatternsinthisareaandeasyobscurationofsentinel
node by the primary injection site. The need for accurate
imaging extends beyond planar lymphoscintigraphy.
SPECT/CT is a new imaging modality that improves pre-
operative lymphatic mapping by exactly localizing sentinel
node. It depicts sentinel nodes that are missed on planar
images, especially nodes in close proximity to the injection
area, and can exclude presumed sentinel nodes that are based
ontracerleakageorcontamination.Sequentialplanarimages
remain essential to distinguish sentinel nodes from second-
echelon nodes.
A portable gamma camera can be used to improve
intraoperative search for sentinel nodes. Such a camera
provides real-time imaging of the sentinel node and can
detect and localize those nodes, even if located near the
injectionarea.Agammacameraincreasescertaintyaboutthe
accuracy and completeness of the excision of the radioactive
nodes, since it facilitates postexcision monitoring.
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